A systematic review on the efficacy of herbal medicines in the management of human drug-induced hyperprolactinemia; potential sources for the development of novel drugs

International Journal of Pharmacology

Volumn 6, Issue 5, 2010, Pages 691-695

  Hasam Ranjbar, S ^a   Vahidi, H ^b   Taslimi, S ^b   Karimi, N ^b   Larijani, B ^a   Abdollahi, M ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antipsychotics; Galactorrhea; Herbal medicine; Hyperprolactinemia; Neuroleptic; New drugs; Prolactinoma; Schizophrenia; Systematic review

Indexed keywords

ALBIFLORIN; BROMOCRIPTINE; CLERODADIENOL DERIVATIVE; DITERPENE; GLYCYRRHETINIC ACID; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; LIQUIRITIN; NEUROLEPTIC AGENT; PAEONIA EXTRACT; PLACEBO; PLANT MEDICINAL PRODUCT; PROLACTIN; RISPERIDONE; SHAKUYAKU KANZO TO; TJ 68; TONGDATANG; UNCLASSIFIED DRUG; ZHUANGYANG;

AMENORRHEA; ARTICLE; CLINICAL TRIAL; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; HERBAL MEDICINE; HUMAN; HYPERPROLACTINEMIA; MEDICINAL PLANT; NONHUMAN; OLIGOMENORRHEA; PROLACTIN BLOOD LEVEL; SCHIZOPHRENIA; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT DURATION; VITEXAGNUS CASTUS;

EID: 77955669303     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.691.695     Document Type: Article

References (33)

1. Casanueva, F.F., M.E. Molitch, J.A. Schlechte, R. Abs and V. Bonert et al, 2006. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin. Endocrinol. (Oxf), 65: 265-273.
2. Chen, Z., G. Wang, X. Wang, L. Li and D. Xiao, 2008. Effects of Zhuangyang capsules on the serum prolactin of schizophrenic patients treated with risperidone. Med. J. Wuhan Univ., 29: 798-800.
3. David, S.R., C.C. Taylor, B.J. Kinon and A. Breier, 2000. The effects of olanzapine, rispiridone and haloperiodol on plasma prolactin levels in patients with schizophrenia. Clin. Ther., 22: 1085-1096.
4. Ding, Y., H.Z. Qian and Y.Q. Wang, 2008. Effect of tongdatang serial recipe on antipsychotic druginduced galactorrhea-amenorrhea syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi, 28: 263-265.
5. Gillam, M.P., M.E. Molitch, G. Lombardi and A. Colao, 2006. Advances in the treatment of prolactinomas. Endocrine Rev., 27: 485-534.
6. Hasani-Ranjbar, S., B. Larijani and M. Abdollahi, 2008. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arch. Med. Sci., 4, 3: 285-292.
7. Hasani-Ranjbar, S., B. Larijani and M. Abdollahi, 2009a. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm. Allergy Drug Targets, 8: 2-10.
8. Hasani-Ranjbar, S., N. Nayebi, B. Larijani and M. Abdollahi, 2009b. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J. Gastroenterol., 15: 3073-3085.
9. Hasani-Ranjbar, S., N. Nayebi, B. Larijani and M. Abdollahi, 2010. A systematic review of the efficacy and safety of Teucrium species; from anti-oxidant to anti-diabetic effects. Int. J. Pharmacol., 6: 315-325.
10. Mancini, T., F.F. Casanueva and A. Giustina, 2008. Hyperprolactinemia and prolactinomas. Endocrinol. Metab. Clin. North Am., 37: 67-99.
11. Markianos, M., J. Hatzimanolis and L. Lykouras, 2001. euroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol. Eur. Arch. Psychiatry Clin. Neurosci., 251: 141-146.
12. McCallum, J.R., R.W. Sowers, J.M. Hershman and R.A.L. Sturdevant, 1976. Metoclopramide stimulates prolactin secretion in man. J. Clin. Endocrinol. Metab., 42: 1148-1152.
13. Moher, D., A.R. Jadad, G. Nichol, M. Penman, P. Tugwell and S. Walsh, 1995. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists. Controlled Clin. Trials, 16: 62-73.
14. Mohseni-Salehi-Monfared, S.S., H. Vahidi, A.H. Abdolghaffari, S. Nikfar and M. Abdollahi, 2009a. Antioxidant therapy in the management of acute, chronic and post-ERCP pancreatitis: A systematic review. World J. Gastroenterol., 15: 4481-4490.
15. Mohseni-Salehi-Monfared, S.S., B. Larijani and M. Abdollahi, 2009b. Islet transplantation and antioxidant management: A systematic review. World J. Gastroenterol, 15: 1153-1161.
16. Momtaz, S. and M. Abdollahi, 2010. An update on pharmacology of satureja species; from antioxidant, antimicrobial, antidiabetes and anti-hyperlipidemic to reproductive stimulation. Int. J. Pharmacol., 6: 454-461.
17. Patel, S.S. and V. Bamigboye, 2007. Hyperprolactinaemia. J. Obstet. Gynaecol, 27: 455-459.
18. Perala, J., J. Suvisaari, S.I. Saarni, K. Kuoppasalmi and E. Isometsa et al, 2007. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry, 64: 19-28.
19. Perovich, R.M., J.A. Lieberman, W.W. Fleischhacker and J. Alvir, 1989. The behavioral toxicity of bromocriptine in patients with psychiatric illness. J. Clin. PsychopharmacoL, 9: 417-422.
20. Rahimi, R., S. Nikfar, B. Lanjani and M. Abdollahi, 2005. A review on the role of antioxidants in the management of diabetes and its complications. Biomed. Pharmacother., 59: 365-373.
21. Rahimi, R., S. Mozaffaii, M. Abdollahi, 2009. On the use of herbal medicines in management of inflammatory bowel diseases: A systematic review of animal and human studies. Dig. Dis. Sci., 54: 471-480.
22. Rahimi, R, S. Ghiasi, H. Azimi, S. Fakhari and M. Abdollahi, 2010. A review of the herbal phosphodiesterase inhibitors: future perspective of new drugs. Cytokine, 49: 123-129.
23. Rivera, J.L., S. Lai, P. Ettigi, S. Hontela, H.F. Muller and H.G. Friesen, 1976. Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups. Clin. Endocrinol., 5: 273-282.
24. Salari, P., A. Rezaie, B. Larijani and M. Abdollahi, 2008. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med. Sci. Monitor, 14: RA37-RA44.
25. Sowers, J.R., B. Sharp and RW. McCallum, 1982. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone and 18-hydroxycorticosterone secretion in man. J. Clin. Endocrinol. Metab., 54: 869-871.
26. Tollm, S.R., 2000. Use of the dopamine agonistsbromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders. J. Endocrinol. Invest., 23: 765-770.
27. Torre, D.L. and A. Falorni, 2007. Pharmacological causes of hyperprolactinemia. Ther. Clin. Risk Manage., 3: 929-951.
28. Vance, ML., W.S. Evans and M.O. Thorner, 1984. Drugs five years later. Bromocriptine. Ann. Intern. Med., 100: 78-91.
29. Wuttke, W., H. Jarry, V. Christoffel, B. Spengler and D. Seidlova-Wuttke, 2003. Chaste tree (Vitexagnuscastus)--pharmacology and clinical indications. Phytomedicme, 10: 348-357.
30. Yamada, K., S. Kanba, T. Murata, M. Fukuzawa, B. Terashi, G. Yagi and M. Asai, 1996. Effectiveness of shakuyaku-kanzo-to in neuroleptic-induced hyperprolactinemia: A preliminary report. Psychiatry Clin. Neurosci., 50: 341-342.
31. Yamada, K., S. Kanba, G. Yagi and M. Asai, 1997. Effectiveness of herbal medicine (shakuyaku-kanzoto) for neuroleptic-induced hyperprolactinemia. J. Clin. Psychopharmacol., 17: 234-235.
32. Yamada, K., G. Yagi and M. Asai, 1999. Herbal medicine (Shakuyaku-kanzo-to) in the treatment of risperidoneinduced amenorrhea. J. Clin. Psychopharmacol., 19: 380-381.
33. Yuan, H.N., C.Y. Wang, C.W. Sze, Y. Tong and Q.R. Tan et al, 2008. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia. J. Clin. Psychopharmacol., 28: 264-270.